Viewing StudyNCT00005576



Ignite Creation Date: 2024-05-05 @ 9:57 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00005576
Status: COMPLETED
Last Update Posted: 2013-01-16
First Post: 2000-05-02

Brief Title: Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Disseminated Neuroblastoma
Recurrent Neuroblastoma
Regional Neuroblastoma
Keywords: